Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00952367
Other study ID # 0887X1-4602
Secondary ID
Status Completed
Phase N/A
First received August 3, 2009
Last updated March 12, 2012
Start date April 2009
Est. completion date March 2010

Study information

Verified date March 2012
Source Wyeth is now a wholly owned subsidiary of Pfizer
Contact n/a
Is FDA regulated No
Health authority China: Ethics Committee
Study type Observational

Clinical Trial Summary

This study is to observe the carriage rate of Streptococcus pneumoniae (S.p.), Haemophilus influenzae Type B (Hib) and Moraxella catarrhalis (M.Cat.) in healthy Chinese children aged 12-18 months in order to estimate the prevalence of pathogens that commonly cause infection in Chinese young children. The antibiotic resistance of all isolates and the serotypes distribution of S.p. isolates will also be tested. Potential risk factors for nasopharyngeal carriage will be collected.


Recruitment information / eligibility

Status Completed
Enrollment 3641
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 12 Months to 18 Months
Eligibility Inclusion Criteria

- Healthy children aged 12-18 months

Exclusion Criteria

- Use of antibiotics up to 15 days prior to study inclusion

- Malformation or injury of the nasopharynx that makes the procedure of taking a nasopharyngeal swab impossible

- Children with chronic infectious (chronic otitis media or chronic sinusitis prior to study inclusion.

- Received any pneumococcal vaccine in the past.

- Children who have already provided a NP sample in the same study period.

- Any relevant hemorrhagic disorder.

- Any febrile process (fever = 38°C) at time of screening.

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Nasopharyngeal swab
Nasopharyngeal swab

Locations

Country Name City State
China Pfizer Investigational Site Beijing Beijing
China Pfizer Investigational Site Dongguan Guangdong
China Pfizer Investigational Site Jinan Shandong
China Pfizer Investigational Site Nanjing Jiangsu
China Pfizer Investigational Site Shanghai Shanghai
China Pfizer Investigational Site Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Wyeth is now a wholly owned subsidiary of Pfizer

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants With Nasopharyngeal Carriage of Streptococcus Pneumoniae A nasopharyngeal swab sample approached via the nasal route was collected. Swab samples were inoculated directly on plates and transferred to local laboratory for culture and isolation of Streptococcus pneumoniae. Percentage of participants in whom Streptococcus pneumoniae was isolated is reported by site. Day 1 No
Primary Percentage of Participants With Serotypes of Streptococcus Pneumoniae Categories are the serotypes of Streptococcus pneumoniae. NO6A/NO6B belongs to Group 6 but is neither 6A nor 6B. NO23F belongs to Group 23 but is not 23F. NO19A/NO19F belongs to Group 19 but is neither 19A nor 19F. Serotypes G, H, D, I, E, F are results of latex agglutination test, and do not refer to a specific serotype; they cannot be further serotyped by the Quellung reaction. NO(Without capsule) includes all Streptococcus pneumoniae isolates that cannot be serotyped because of no capsule. Day 1 No
Secondary Percentage of Participants With Nasopharyngeal Carriage of Haemophilus Influenzae Type B A nasopharyngeal swab sample approached via the nasal route was collected. Swab samples were inoculated directly on plates and transferred to local laboratory for culture and isolation of Haemophilus influenzae type B. Percentage of participants in whom Haemophilus influenzae type B was isolated is reported by site. Day 1 No
Secondary Percentage of Participants With Nasopharyngeal Carriage of Moraxella Catarrhalis A nasopharyngeal swab sample approached via the nasal route was collected. Swab samples were inoculated directly on plates and transferred to local laboratory for culture and isolation of Moraxella catarrhalis. Percentage of participants in whom Moraxella catarrhalis was isolated is reported by site. Day 1 No
Secondary Percentage of Streptococcus Pneumoniae Isolates Resistant to Antibiotics Categories are types of antibiotics. Penicillin (Old Criteria): Criteria of non-meningitis Streptococcus pneumoniae isolates resistant to penicillin were changed in Clinical Laboratory and Standards Institute (CLSI) in 2008. Criteria in CLSI before 2008 were the old criteria. Day 1 No
Secondary Percentage of Haemophilus Influenzae Type B Isolates Resistant to Antibiotics Categories are types of antibiotics. Day 1 No
Secondary Percentage of Moraxella Catarrhalis Isolates Resistant to Antibiotics Categories are types of antibiotics. Day 1 No
Secondary Risk Factors Associated With Nasopharyngeal Carriage for Streptococcus Pneumoniae Risk factors include age of mother bearing (less than or equal to [<=] 30 years versus [vs] more than [>] 30 years); household register (local vs nonlocal); mother's education level (illiteracy, elementary school, junior middle school, senior/vocational high school or technical, college/university vs postgraduate and above); family monthly income per capita (below 600 Chinese Renminbi [RMB], 600 RMB to 1999 RMB, 2000 RMB to 4999 RMB, 5000 RMB to 7999 RMB, 8000 RMB to 9999 RMB vs more than or equal to [>=] 10000 RMB); whether have brothers or sisters (yes vs no). Day 1 No
Secondary Risk Factors Associated With Nasopharyngeal Carriage for Haemophilus Influenzae Type B Risk factors include birth information (preterm vs full-term birth); household register (local vs nonlocal); feeding manners within 6 months (pure breast feeding, mixed feeding vs pure formula milk feeding); father's education level (illiteracy, elementary school, junior middle school, senior/vocational high school or technical, college/university vs postgraduate and above); living space per capita (continuous variables); vaccination history of Haemophilus influenzae type B (Hib) (no vs yes). Day 1 No
Secondary Risk Factors Associated With Nasopharyngeal Carriage for Moraxella Catarrhalis Risk factors include birth information (preterm vs full-term birth); household register (local vs nonlocal); mother's education level (illiteracy, elementary school, junior middle school, senior/vocational high school or technical, college/university, vs postgraduate and above); whether have brothers or sisters (no vs yes). Day 1 No
See also
  Status Clinical Trial Phase
Completed NCT01446926 - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Phase 1
Completed NCT01444352 - Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults Phase 1
Completed NCT00471822 - Nasopharyngeal Streptococcus Pneumoniae Carriage N/A
Completed NCT01444339 - Study of Two Investigational Pneumococcal Vaccines in Healthy Adults Phase 1